Back

A protective device for the pathological process of graft vein restenosis after CABG

28 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Coronary artery bypass grafting and surgical treatment secondary mitral regurgitation Coronary Arteries ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Bolin Wang

Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Evolution of surgical management for anomalous aortic origin of a coronary artery (AAOCA): broadening the understanding of a complex lesion
Doctor A. Srivatsav (Houston, US) Associate Professor S. Molossi (Houston, US)
Abstract Slides
Presentation thumbnail
Survival after coronary artery bypass grafting with or without mitral valve repair for moderate ischemic mitral regurgitation
Mr L. Chen (Beijing, CN)
Abstract Slides
Presentation thumbnail
Sternal Infection Burden Index (SIBI-S) for risk stratification of sternal wound infection after isolated coronary artery bypass grafting: an international multicenter cohort study
Doctor O. Ayyad (Rehovot, IL)
Abstract Slides
Presentation thumbnail
Survival in octogenarian patients undergoing coronary artery bypass grafting: on-pump vs off-pump
Miss G. Rinaldi (PT)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery bypass grafting and surgical treatment secondary mitral regurgitation

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
A novel therapeutic approach for coronary inflammation and lymphatic vessels using non-invasive low-intensity pulsed ultrasound in a porcine model with DES-induced coronary hyperconstricting responses
30 August 2020
thumbnail
Congress Presentation
Coronary graft aneurysm as a rare late complication following CABG: a case report
11 December 2025
thumbnail
Congress Presentation
The novel proteomic signature for the detection of cardiac allograft vasculopathy
27 August 2021
thumbnail
Congress Presentation
Long-term outcomes of the micronet-covered stent system routine use for carotid revsacularization in stroke prevention: PARADIGM-Extend 5 year evidence
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources